Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M β-lactamases  J.-P. Lavigne, A.-B. Blanc-Potard,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Thirty-day mortality of nosocomial systemic bacterial infections according to antibiotic susceptibility in an 800-bed teaching hospital in France  D.
Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001 
S. Biswas, D. Raoult, J.-M. Rolain  Clinical Microbiology and Infection 
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
Gut bacterial microbiota and obesity
Evolution of extended-spectrum β-lactamases by mutation
In vitro effects of cefotaxime and ceftriaxone on Salmonella typhi within human monocyte-derived macrophages  B. Ekinci, A.Y. Coban, A. Birinci, B. Durupinar,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
Membrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates  J.-P. Lavigne,
Virological tools to diagnose and monitor hepatitis C virus infection
E. Lindberg, I. Adlerberth, A.E. Wold 
Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints  L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.
N. Messad, L. Landraud, B. Canivet, G. Lina, J. -L. Richard, A
Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from Finland  M. Eklund, M. Bielaszewska, U.-M. Nakari,
Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001 
S. Biswas, D. Raoult, J.-M. Rolain  Clinical Microbiology and Infection 
Membrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates  J.-P. Lavigne,
The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents  S. Brown, S.G.B. Amyes  Clinical.
Louis Pasteur, from crystals of life to vaccination
Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli  R.A. Hickman, D. Hughes,
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
Escherichia coli native valve endocarditis
Vector control: a cornerstone in the malaria elimination campaign
Pharmacodynamics of doxycycline
Molecular mechanism of gentamicin resistance in Bartonella henselae
New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
CMI editorial report 2011 Clinical Microbiology and Infection
Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin- clavulanate and piperacillin-tazobactam with extended-spectrum.
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,
Development and clinical validation of a molecular diagnostic assay to detect CTX-M- type β-lactamases in Enterobacteriaceae  J.D.D. Pitout, N. Hamilton,
Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community  R.E. Warren, G. Harvey, R. Carr, D. Ward,
Aerococcus: an increasingly acknowledged human pathogen
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Metagenomics and probiotics
A. Bryskier  Clinical Microbiology and Infection 
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
P.M. Hawkey  Clinical Microbiology and Infection 
Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China  Y. Luo, Y. Wang, L. Ye, J. Yang  Clinical.
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
C. Gagliotti, L. Nobilio, M.L. Moro 
Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain  L. Vinué, Y. Sáenz, S. Martínez,
An after-hours clinical liaison blood culture service—is it worth it?
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobactet species  K. Lee, Y. Chong,
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting  A. Kronenberg, S. Koenig, S. Droz,
Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species  G. Kronvall, E. Holst  Clinical Microbiology.
Predominance of SHV-5 β-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina  S. Uzunovic-Kamberovic,
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
G. Kahlmeter  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
High prevalence of mutators among Enterobacter cloacae nosocomial isolates and their association with antimicrobial resistance and repetitive detection 
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M β-lactamases  J.-P. Lavigne, A.-B. Blanc-Potard, G. Bourg, J. Moreau, C. Chanal, N. Bouziges, D. O'Callaghan, A. Sotto  Clinical Microbiology and Infection  Volume 12, Issue 12, Pages 1199-1206 (December 2006) DOI: 10.1111/j.1469-0691.2006.01536.x Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Kinetics of killing of Caenorhabditis elegans infected by CTX-M-producing Escherichia coli (circles), TEM-producing E. coli (triangles), and susceptible E. coli (squares). For each group of isolates (CTX-M, TEM and susceptible), four isolates representative of the results are shown. The line with crosses shows the survival curve for C. elegans fed with the nonpathogenic E. coli OP50 strain. In all cases, C. elegans was grown on NGM agar plates [31] at 25°C, with 20–30 N2 hermaphrodites used in each test. The curves are representative of at least three independent trials for each group of isolates. Clinical Microbiology and Infection 2006 12, 1199-1206DOI: (10.1111/j.1469-0691.2006.01536.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions